Get started
Author

Nuria Maroto

Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study
2021 · María Chaparro, Ana Garre, et al. · Journal of Clinical Medicine · 105
Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: A multicenter study
2011 · Barreiro-de M. Acosta, O. García-Bosch, et al. · Inflammatory Bowel Diseases · 102
Tuberculosis in Anti-Tumour Necrosis Factor-treated Inflammatory Bowel Disease Patients After the Implementation of Preventive Measures: Compliance With Recommendations and Safety of Retreatment
2016 · D. Carpio, A. Jauregui-Amezaga, et al. · Journal of Crohn s and Colitis · 41
High Prevalence of Heartburn and Low Acid Sensitivity in Patients with Idiopathic Achalasia
2010 · Julio Ponce, Vicente Ortiz, et al. · Digestive Diseases and Sciences · 40
Short-term effectiveness of golimumab for ulcerative colitis: Observational multicenter study
2016 · Marta Maia Bosca-Watts, Xavier Cortes, et al. · World Journal of Gastroenterology · 35
PDF
Recomendaciones del Grupo Español de Trabajo de Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) para el tratamiento de las fístulas perianales de la enfermedad de Crohn
2019 · Marta M. Boscá, Rafael Alós, et al. · Gastroenterología y Hepatología · 30
PDF
Incidence of adult form of autoimmune hepatitis in Valencia (Spain).
2009 · J Primo, N Maroto, et al. · PubMed · 29
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain
2019 · María Chaparro, Manuel Barreiro-de Acosta, et al. · Therapeutic Advances in Gastroenterology · 24
Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn’s Disease: A National, Multicentre Study Based on ENEIDA Registry
2023 · Diego Casas Deza, Cristina Polo Cuadro, et al. · Journal of Crohn s and Colitis · 23
PDF
Ferric Carboxymaltose Improves the Quality of Life of Patients with Inflammatory Bowel Disease and Iron Deficiency without Anaemia
2022 · Jose María Huguet, Xavier Cortés, et al. · Journal of Clinical Medicine · 13
PDF
Severe Myalgia Associated with Adalimumab Treatment in a Patient with Crohn's Disease
2008 · Joaquín Hinojosa, Joaquín Borrás-Blasco, et al. · Annals of Pharmacotherapy · 10
Recommendations of the Crohn’s Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn’s disease
2020 · Marta M. Boscá, Rafael Alós, et al. · Gastroenterología y Hepatología (English Edition) · 9
Outcome of Patients with Nonstenotic, Nonfistulizing Crohn’s Disease
2004 · Pilar Nos, Vicente Garrigues, et al. · Digestive Diseases and Sciences · 9
Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCU
2025 · L Madero‐Velázquez, A Mínguez, et al. · United European Gastroenterology Journal · 8
PDF
Real-world data on the infliximab biosimilar CT-P13 (Remsima®) in inflammatory bowel disease
2021 · Jose María Huguet, Xavier Cortés, et al. · World Journal of Clinical Cases · 8
Inflammatory bowel disease in patients over the age of 70 y. Does the disease duration influence its behavior?
2018 · Jose M. Huguet, Marisa Iborra, et al. · Scandinavian Journal of Gastroenterology · 8
Vedolizumab, una opción en pacientes con enfermedad inflamatoria intestinal intolerantes a tiopurinas y refractarios a biológicos
2018 · Marisa Iborra, Belén Beltrán, et al. · Gastroenterología y Hepatología · 7
A new guidewire cannulation technique in ERCP: successful deep biliary access with triple-lumen sphincterotome and guidewire controlled by the endoscopist
2010 · Antonio López, Isabel Ferrer, et al. · Surgical Endoscopy · 7
Real‐World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry
2026 · Manuel Barreiro‐de Acosta, Yamile Zabana, et al. · Alimentary Pharmacology & Therapeutics · 5
PDF
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885
2022 · María Chaparro, Ana Garre, et al. · Journal of Clinical Medicine · 4
P714 Vedolizumab, an adequate option in medically refractory and thiopurine-intolerant inflammatory bowel disease patients
2018 · M Iborra, N Maroto, et al. · Journal of Crohn s and Colitis · 3
Efficacy of Infliximab Rescue Therapy in Patients With Chronic Refractory Pouchitis: A Multicenter Study
2011 · Manuel Barreiro-de Acosta, Raquel Souto, et al. · Gastroenterology · 3
PDF
Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry
2025 · Míriam Mañosa, Margalida Calafat, et al. · United European Gastroenterology Journal · 2
PDF
Validation of a population pharmacokinetic model of adalimumab in a cohort of patients with inflammatory bowel disease
2019 · Gregorio J. Martínez-Romero, Ana Alvariño, et al. · Revista Española de Enfermedades Digestivas · 2
Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents
2018 · Marisa Iborra, Belén Beltrán, et al. · Gastroenterología y Hepatología (English Edition) · 2
Works count: 48
Citation count: 534
H-index: 10
I10-index: 11
Year
Topic
Type